STATE OF WISCONSIN
CONTROLLED SUBSTANCES BOARD
---------------------------------------------------------------------------------------------------------------------
IN THE MATTER OF RULE-MAKING : AFFIRMATIVE ACTION
PROCEEDINGS BEFORE THE : ORDER OF THE
CONTROLLED SUBSTANCES BOARD : CONTROLLED SUBSTANCES BOARD
---------------------------------------------------------------------------------------------------------------------
FINDINGS
1. On March 10, 2020, the Department of Justice, Drug Enforcement Administration published its interim final rule in the Federal Register placing cenobamate into schedule Vof the federal Controlled Substances Act. The scheduling action is effective March 10, 2020.
2. The Controlled Substances Board did not receive an objection to similarly treating cenobamate as a schedule V under ch. 961, Stats. within 30 days of the date of publication in the federal register of the final order designating cenobamate as a controlled substance. 3. The Controlled Substances Board will promulgate a final rule, without making the determinations or findings required by ss. 961.11(1), (1m), (1r) and (2) or s. 961.21 and omitting the notice of proposed rule making, designating cenobamate as a schedule V controlled substance. ORDER
Pursuant to s. 961.11(4), Stats., the Controlled Substances Board by affirmative action similarly treats cenobamate under chapter 961, Stats. by creating the following: CSB 2.73 Addition of cenobamate to schedule V. Section 961.22 (9), Stats., is created to read: 961.22 (9) Cenobamate Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester)
This order shall take effect on May 18, 2020 to allow for publication in the Administrative Register. The order expires upon promulgation of a final rule.
Dated May 8, 2020 
Doug Englebert, Chair
Controlled Substances Board
